{"id":"https://openalex.org/W4390322684","doi":"https://doi.org/10.1182/bloodadvances.2023011078","title":"Pediatric transplant\u2013associated thrombotic microangiopathy health care utilization and implications of eculizumab therapy","display_name":"Pediatric transplant\u2013associated thrombotic microangiopathy health care utilization and implications of eculizumab therapy","publication_year":2023,"publication_date":"2023-12-28","ids":{"openalex":"https://openalex.org/W4390322684","doi":"https://doi.org/10.1182/bloodadvances.2023011078","pmid":"https://pubmed.ncbi.nlm.nih.gov/38154068","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/10912836"},"language":"en","primary_location":{"id":"doi:10.1182/bloodadvances.2023011078","doi":"https://doi.org/10.1182/bloodadvances.2023011078","is_oa":true,"landing_page_url":"https://doi.org/10.1182/bloodadvances.2023011078","pdf_url":"https://ashpublications.org/bloodadvances/article-pdf/doi/10.1182/bloodadvances.2023011078/2179333/bloodadvances.2023011078.pdf","source":{"id":"https://openalex.org/S2764683450","display_name":"Blood Advances","issn_l":"2473-9529","issn":["2473-9529","2473-9537"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-1","ki-jl-2","medline","norway-1","oarl","poland-40","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood Advances","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://ashpublications.org/bloodadvances/article-pdf/doi/10.1182/bloodadvances.2023011078/2179333/bloodadvances.2023011078.pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5046929879","display_name":"Michelle Long Schoettler","orcid":"https://orcid.org/0000-0003-4565-6399","observed_orcids":["https://orcid.org/0000-0003-4565-6399"]},"institutions":[{"id":"https://openalex.org/I150468666","display_name":"Emory University","ror":"https://ror.org/03czfpz43","country_code":"US","type":"education","lineage":["https://openalex.org/I150468666"]},{"id":"https://openalex.org/I4210146983","display_name":"Children's Healthcare of Atlanta","ror":"https://ror.org/050fhx250","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210146983"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Michelle L. Schoettler","raw_affiliation_strings":["1Division Blood and Marrow Transplantation, Department of Pediatrics, Aflac Cancer and Blood Disorders Center, Children\u2019s Healthcare of Atlanta, Emory University, Atlanta, GA","Aflac Cancer and Blood Disorders Center of Children's Healthcare of Atlanta and Emory University, Atlanta, Georgia, United States"],"raw_orcid":"https://orcid.org/0000-0003-4565-6399","affiliations":[{"raw_affiliation_string":"1Division Blood and Marrow Transplantation, Department of Pediatrics, Aflac Cancer and Blood Disorders Center, Children\u2019s Healthcare of Atlanta, Emory University, Atlanta, GA","institution_ids":["https://openalex.org/I150468666","https://openalex.org/I4210146983"]},{"raw_affiliation_string":"Aflac Cancer and Blood Disorders Center of Children's Healthcare of Atlanta and Emory University, Atlanta, Georgia, United States","institution_ids":["https://openalex.org/I150468666","https://openalex.org/I4210146983"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5008479139","display_name":"Leslie Lehmann","orcid":"https://orcid.org/0000-0001-5558-4830","observed_orcids":["https://orcid.org/0000-0001-5558-4830"]},"institutions":[{"id":"https://openalex.org/I1288882113","display_name":"Boston Children's Hospital","ror":"https://ror.org/00dvg7y05","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1288882113"]},{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]},{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]},{"id":"https://openalex.org/I4210166317","display_name":"Dana-Farber/Boston Children's Cancer and Blood Disorders Center","ror":"https://ror.org/05k11pb55","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1288882113","https://openalex.org/I4210117453","https://openalex.org/I4210166317"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Leslie Lehmann","raw_affiliation_strings":["2Dana Farber/Boston Children\u2019s Cancer and Blood Disorders Center, Harvard Medical School, Boston, MA","Dana-Farber Cancer Institute / Children's Hospital, Boston, Boston, Massachusetts, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Dana Farber/Boston Children\u2019s Cancer and Blood Disorders Center, Harvard Medical School, Boston, MA","institution_ids":["https://openalex.org/I136199984","https://openalex.org/I4210166317"]},{"raw_affiliation_string":"Dana-Farber Cancer Institute / Children's Hospital, Boston, Boston, Massachusetts, United States","institution_ids":["https://openalex.org/I1288882113","https://openalex.org/I4210117453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5053168617","display_name":"Pei\u2010Chi Kao","orcid":"https://orcid.org/0000-0003-0702-8324","observed_orcids":["https://orcid.org/0000-0003-0702-8324"]},"institutions":[{"id":"https://openalex.org/I1288882113","display_name":"Boston Children's Hospital","ror":"https://ror.org/00dvg7y05","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1288882113"]},{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]},{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]},{"id":"https://openalex.org/I4210166317","display_name":"Dana-Farber/Boston Children's Cancer and Blood Disorders Center","ror":"https://ror.org/05k11pb55","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1288882113","https://openalex.org/I4210117453","https://openalex.org/I4210166317"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Pei-Chi Kao","raw_affiliation_strings":["2Dana Farber/Boston Children\u2019s Cancer and Blood Disorders Center, Harvard Medical School, Boston, MA","Boston Children's Hospital/Dana-Farber Cancer Institute, Boston, Massachusetts, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Dana Farber/Boston Children\u2019s Cancer and Blood Disorders Center, Harvard Medical School, Boston, MA","institution_ids":["https://openalex.org/I136199984","https://openalex.org/I4210166317"]},{"raw_affiliation_string":"Boston Children's Hospital/Dana-Farber Cancer Institute, Boston, Massachusetts, United States","institution_ids":["https://openalex.org/I1288882113","https://openalex.org/I4210117453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100442873","display_name":"Nan Chen","orcid":"https://orcid.org/0009-0007-4593-0972","observed_orcids":["https://orcid.org/0009-0007-4593-0972"]},"institutions":[{"id":"https://openalex.org/I1288882113","display_name":"Boston Children's Hospital","ror":"https://ror.org/00dvg7y05","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1288882113"]},{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]},{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]},{"id":"https://openalex.org/I4210166317","display_name":"Dana-Farber/Boston Children's Cancer and Blood Disorders Center","ror":"https://ror.org/05k11pb55","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1288882113","https://openalex.org/I4210117453","https://openalex.org/I4210166317"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Nan Chen","raw_affiliation_strings":["2Dana Farber/Boston Children\u2019s Cancer and Blood Disorders Center, Harvard Medical School, Boston, MA","Boston Children's Hospital/Dana-Farber Cancer Institute, Boston, Massachusetts, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Dana Farber/Boston Children\u2019s Cancer and Blood Disorders Center, Harvard Medical School, Boston, MA","institution_ids":["https://openalex.org/I136199984","https://openalex.org/I4210166317"]},{"raw_affiliation_string":"Boston Children's Hospital/Dana-Farber Cancer Institute, Boston, Massachusetts, United States","institution_ids":["https://openalex.org/I1288882113","https://openalex.org/I4210117453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5011524144","display_name":"Sonata Jodele","orcid":"https://orcid.org/0000-0002-1791-7718","observed_orcids":["https://orcid.org/0000-0002-1791-7718"]},"institutions":[{"id":"https://openalex.org/I1285204247","display_name":"Cincinnati Children's Hospital Medical Center","ror":"https://ror.org/01hcyya48","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1285204247"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Sonata Jodele","raw_affiliation_strings":["3Division of Bone Marrow Transplantation and Immune Deficiency, Department of Pediatrics, Cincinnati Children\u2019s Medical Center, Cincinnati, OH","Division of Bone Marrow Transplantation and Immune Deficiency, Cancer and Blood Disease Institute, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"3Division of Bone Marrow Transplantation and Immune Deficiency, Department of Pediatrics, Cincinnati Children\u2019s Medical Center, Cincinnati, OH","institution_ids":["https://openalex.org/I1285204247"]},{"raw_affiliation_string":"Division of Bone Marrow Transplantation and Immune Deficiency, Cancer and Blood Disease Institute, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, United States","institution_ids":["https://openalex.org/I1285204247"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5063350418","display_name":"Satheesh Chonat","orcid":"https://orcid.org/0000-0002-5909-0800","observed_orcids":["https://orcid.org/0000-0002-5909-0800"]},"institutions":[{"id":"https://openalex.org/I150468666","display_name":"Emory University","ror":"https://ror.org/03czfpz43","country_code":"US","type":"education","lineage":["https://openalex.org/I150468666"]},{"id":"https://openalex.org/I4210146983","display_name":"Children's Healthcare of Atlanta","ror":"https://ror.org/050fhx250","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210146983"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Satheesh Chonat","raw_affiliation_strings":["1Division Blood and Marrow Transplantation, Department of Pediatrics, Aflac Cancer and Blood Disorders Center, Children\u2019s Healthcare of Atlanta, Emory University, Atlanta, GA","Emory University School of Medicine, Atlanta, Georgia, United States"],"raw_orcid":"https://orcid.org/0000-0002-5909-0800","affiliations":[{"raw_affiliation_string":"1Division Blood and Marrow Transplantation, Department of Pediatrics, Aflac Cancer and Blood Disorders Center, Children\u2019s Healthcare of Atlanta, Emory University, Atlanta, GA","institution_ids":["https://openalex.org/I150468666","https://openalex.org/I4210146983"]},{"raw_affiliation_string":"Emory University School of Medicine, Atlanta, Georgia, United States","institution_ids":["https://openalex.org/I150468666"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5036788225","display_name":"Kirsten M. Williams","orcid":"https://orcid.org/0000-0001-9372-5286","observed_orcids":["https://orcid.org/0000-0001-9372-5286"]},"institutions":[{"id":"https://openalex.org/I150468666","display_name":"Emory University","ror":"https://ror.org/03czfpz43","country_code":"US","type":"education","lineage":["https://openalex.org/I150468666"]},{"id":"https://openalex.org/I4210146983","display_name":"Children's Healthcare of Atlanta","ror":"https://ror.org/050fhx250","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210146983"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Kirsten M. Williams","raw_affiliation_strings":["1Division Blood and Marrow Transplantation, Department of Pediatrics, Aflac Cancer and Blood Disorders Center, Children\u2019s Healthcare of Atlanta, Emory University, Atlanta, GA","Aflac Cancer and Blood Disorders Center of Children's Healthcare of Atlanta and Emory University Department of Pediatrics, Atlanta, Georgia, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Division Blood and Marrow Transplantation, Department of Pediatrics, Aflac Cancer and Blood Disorders Center, Children\u2019s Healthcare of Atlanta, Emory University, Atlanta, GA","institution_ids":["https://openalex.org/I150468666","https://openalex.org/I4210146983"]},{"raw_affiliation_string":"Aflac Cancer and Blood Disorders Center of Children's Healthcare of Atlanta and Emory University Department of Pediatrics, Atlanta, Georgia, United States","institution_ids":["https://openalex.org/I150468666","https://openalex.org/I4210146983"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5003639088","display_name":"Wendy B. London","orcid":"https://orcid.org/0000-0003-3571-6538","observed_orcids":["https://orcid.org/0000-0003-3571-6538"]},"institutions":[{"id":"https://openalex.org/I1288882113","display_name":"Boston Children's Hospital","ror":"https://ror.org/00dvg7y05","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1288882113"]},{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]},{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]},{"id":"https://openalex.org/I4210166317","display_name":"Dana-Farber/Boston Children's Cancer and Blood Disorders Center","ror":"https://ror.org/05k11pb55","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1288882113","https://openalex.org/I4210117453","https://openalex.org/I4210166317"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Wendy B. London","raw_affiliation_strings":["2Dana Farber/Boston Children\u2019s Cancer and Blood Disorders Center, Harvard Medical School, Boston, MA","Boston Children's Hospital, Dana-Farber Cancer Institute, Boston, Massachusetts, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Dana Farber/Boston Children\u2019s Cancer and Blood Disorders Center, Harvard Medical School, Boston, MA","institution_ids":["https://openalex.org/I136199984","https://openalex.org/I4210166317"]},{"raw_affiliation_string":"Boston Children's Hospital, Dana-Farber Cancer Institute, Boston, Massachusetts, United States","institution_ids":["https://openalex.org/I1288882113","https://openalex.org/I4210117453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110543173","display_name":"Christine Duncan","orcid":"https://orcid.org/0000-0002-2090-4897","observed_orcids":["https://orcid.org/0000-0002-2090-4897"]},"institutions":[{"id":"https://openalex.org/I1288882113","display_name":"Boston Children's Hospital","ror":"https://ror.org/00dvg7y05","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1288882113"]},{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]},{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]},{"id":"https://openalex.org/I4210166317","display_name":"Dana-Farber/Boston Children's Cancer and Blood Disorders Center","ror":"https://ror.org/05k11pb55","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1288882113","https://openalex.org/I4210117453","https://openalex.org/I4210166317"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Christine Duncan","raw_affiliation_strings":["2Dana Farber/Boston Children\u2019s Cancer and Blood Disorders Center, Harvard Medical School, Boston, MA","Dana Farber Cancer Institute, Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Dana Farber/Boston Children\u2019s Cancer and Blood Disorders Center, Harvard Medical School, Boston, MA","institution_ids":["https://openalex.org/I136199984","https://openalex.org/I4210166317"]},{"raw_affiliation_string":"Dana Farber Cancer Institute, Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts, United States","institution_ids":["https://openalex.org/I1288882113","https://openalex.org/I136199984","https://openalex.org/I4210117453"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5064454163","display_name":"Christopher E. Dandoy","orcid":"https://orcid.org/0000-0002-4001-9203","observed_orcids":["https://orcid.org/0000-0002-4001-9203"]},"institutions":[{"id":"https://openalex.org/I1285204247","display_name":"Cincinnati Children's Hospital Medical Center","ror":"https://ror.org/01hcyya48","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1285204247"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Christopher Dandoy","raw_affiliation_strings":["3Division of Bone Marrow Transplantation and Immune Deficiency, Department of Pediatrics, Cincinnati Children\u2019s Medical Center, Cincinnati, OH","Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, United States"],"raw_orcid":"https://orcid.org/0000-0002-4001-9203","affiliations":[{"raw_affiliation_string":"3Division of Bone Marrow Transplantation and Immune Deficiency, Department of Pediatrics, Cincinnati Children\u2019s Medical Center, Cincinnati, OH","institution_ids":["https://openalex.org/I1285204247"]},{"raw_affiliation_string":"Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, United States","institution_ids":["https://openalex.org/I1285204247"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":7,"corresponding_author_ids":["https://openalex.org/A5046929879"],"corresponding_institution_ids":["https://openalex.org/I150468666","https://openalex.org/I4210146983"],"apc_list":{"value":3000,"currency":"USD","value_usd":3000},"apc_paid":{"value":3000,"currency":"USD","value_usd":3000},"fwci":0.6544,"has_fulltext":true,"cited_by_count":6,"citation_normalized_percentile":{"value":0.64149431,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":94,"max":98},"biblio":{"volume":"8","issue":"5","first_page":"1220","last_page":"1233"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10993","display_name":"Complement system in diseases","score":0.9804999828338623,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10993","display_name":"Complement system in diseases","score":0.9804999828338623,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10345","display_name":"Hematopoietic Stem Cell Transplantation","score":0.015399999916553497,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10373","display_name":"Renal Transplantation Outcomes and Treatments","score":0.0015999999595806003,"subfield":{"id":"https://openalex.org/subfields/2747","display_name":"Transplantation"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/transplant-associated-thrombotic-microangiopathy","display_name":"transplant-associated thrombotic microangiopathy","score":0.9739999771118164},{"id":"https://openalex.org/keywords/pediatric-hematopoietic-stem-cell-transplantation","display_name":"pediatric hematopoietic stem cell transplantation","score":0.8700000047683716},{"id":"https://openalex.org/keywords/eculizumab","display_name":"eculizumab","score":0.984000027179718},{"id":"https://openalex.org/keywords/health-care-utilization","display_name":"health care utilization","score":0.6859999895095825},{"id":"https://openalex.org/keywords/hospitalization-costs","display_name":"hospital costs","score":0.824999988079071},{"id":"https://openalex.org/keywords/graft-versus-host-disease","display_name":"graft-versus-host disease","score":0.921999990940094},{"id":"https://openalex.org/keywords/gastrointestinal-bleeding","display_name":"gastrointestinal bleeding","score":0.8690000176429749},{"id":"https://openalex.org/keywords/cost-of-care","display_name":"cost of care","score":0.3709999918937683}],"concepts":[{"id":"https://openalex.org/C2777991916","wikidata":"https://www.wikidata.org/wiki/Q421617","display_name":"Eculizumab","level":4,"score":0.9643352031707764},{"id":"https://openalex.org/C2777878052","wikidata":"https://www.wikidata.org/wiki/Q3312044","display_name":"Thrombotic microangiopathy","level":3,"score":0.9058360457420349},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7189840078353882},{"id":"https://openalex.org/C177713679","wikidata":"https://www.wikidata.org/wiki/Q679690","display_name":"Intensive care medicine","level":1,"score":0.533161997795105},{"id":"https://openalex.org/C2776513394","wikidata":"https://www.wikidata.org/wiki/Q1412400","display_name":"Microangiopathy","level":3,"score":0.4197496771812439},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.32602453231811523},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.31302610039711},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.18257850408554077},{"id":"https://openalex.org/C111684460","wikidata":"https://www.wikidata.org/wiki/Q334848","display_name":"Complement system","level":3,"score":0.14485099911689758},{"id":"https://openalex.org/C555293320","wikidata":"https://www.wikidata.org/wiki/Q12206","display_name":"Diabetes mellitus","level":2,"score":0.1024288535118103},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.09024906158447266},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.07666993141174316}],"mesh":[{"descriptor_ui":"D002648","descriptor_name":"Child","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006086","descriptor_name":"Graft vs Host Disease","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D006086","descriptor_name":"Graft vs Host Disease","qualifier_ui":"Q000209","qualifier_name":"etiology","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010342","descriptor_name":"Patient Acceptance of Health Care","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012189","descriptor_name":"Retrospective Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018380","descriptor_name":"Hematopoietic Stem Cell Transplantation","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D061067","descriptor_name":"Antibodies, Monoclonal, Humanized","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false}],"locations_count":3,"locations":[{"id":"doi:10.1182/bloodadvances.2023011078","doi":"https://doi.org/10.1182/bloodadvances.2023011078","is_oa":true,"landing_page_url":"https://doi.org/10.1182/bloodadvances.2023011078","pdf_url":"https://ashpublications.org/bloodadvances/article-pdf/doi/10.1182/bloodadvances.2023011078/2179333/bloodadvances.2023011078.pdf","source":{"id":"https://openalex.org/S2764683450","display_name":"Blood Advances","issn_l":"2473-9529","issn":["2473-9529","2473-9537"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-1","ki-jl-2","medline","norway-1","oarl","poland-40","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood Advances","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:10912836","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/10912836","pdf_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC10912836/pdf/main.pdf","source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood Adv","raw_type":"Text"},{"id":"pmid:38154068","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/38154068","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood advances","raw_type":"Multicenter Study"}],"best_oa_location":{"id":"doi:10.1182/bloodadvances.2023011078","doi":"https://doi.org/10.1182/bloodadvances.2023011078","is_oa":true,"landing_page_url":"https://doi.org/10.1182/bloodadvances.2023011078","pdf_url":"https://ashpublications.org/bloodadvances/article-pdf/doi/10.1182/bloodadvances.2023011078/2179333/bloodadvances.2023011078.pdf","source":{"id":"https://openalex.org/S2764683450","display_name":"Blood Advances","issn_l":"2473-9529","issn":["2473-9529","2473-9537"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-1","ki-jl-2","medline","norway-1","oarl","poland-40","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood Advances","raw_type":"journal-article"},"sustainable_development_goals":[{"score":1.0,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[{"display_name":"Observational Study","id":"https://openalex.org/study-designs/observational-study"}],"awards":[{"id":"https://openalex.org/G5241415837","display_name":null,"funder_award_id":"NIH K12","funder_id":"https://openalex.org/F4320332161","funder_display_name":"National Institutes of Health"}],"funders":[{"id":"https://openalex.org/F4320332161","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88"},{"id":"https://openalex.org/F4320337351","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81"}],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4390322684.pdf","grobid_xml":"https://content.openalex.org/works/W4390322684.grobid-xml"},"referenced_works_count":24,"referenced_works":["https://openalex.org/W1922740691","https://openalex.org/W1993215990","https://openalex.org/W2019154801","https://openalex.org/W2027672459","https://openalex.org/W2090522620","https://openalex.org/W2152197116","https://openalex.org/W2413369889","https://openalex.org/W2792985650","https://openalex.org/W2799295920","https://openalex.org/W2885870659","https://openalex.org/W2887339279","https://openalex.org/W2900428445","https://openalex.org/W2973333708","https://openalex.org/W3000105648","https://openalex.org/W3009426607","https://openalex.org/W3011238051","https://openalex.org/W3024177384","https://openalex.org/W3033416765","https://openalex.org/W3090724433","https://openalex.org/W3113832250","https://openalex.org/W4308257579","https://openalex.org/W4309963096","https://openalex.org/W4313656818","https://openalex.org/W4319263479"],"related_works":["https://openalex.org/W4407977533","https://openalex.org/W4308257579","https://openalex.org/W4286500684","https://openalex.org/W4393237260","https://openalex.org/W3213074348","https://openalex.org/W7155489043","https://openalex.org/W2809099134","https://openalex.org/W3001130577","https://openalex.org/W2908566839","https://openalex.org/W4319263208"],"abstract_inverted_index":{"ABSTRACT:":[0],"The":[1,17],"health":[2],"care":[3,178,200],"use":[4],"(HCU)":[5],"burden":[6],"of":[7,19,74,222],"transplant-associated":[8],"thrombotic":[9],"microangiopathy":[10],"(TA-TMA)":[11],"and":[12,76,90,98,131,230,241],"its":[13],"treatments":[14],"are":[15,216],"unknown.":[16],"objective":[18],"this":[20],"study":[21,48],"was":[22,81,151,207],"to":[23,59,92,109,218,235],"investigate":[24],"inpatient":[25,79],"costs":[26,134,163,225],"associated":[27,153,209],"with":[28,154,210,228],"meeting":[29],"criteria":[30],"for":[31,68,78,122,186],"TA-TMA":[32,139,145],"in":[33,72,138,167,175,192,226],"the":[34,84,168,176,193,220],"first":[35],"year":[36],"after":[37,111,120,184],"hematopoietic":[38],"cell":[39,107],"transplant":[40,118],"(HCT).":[41],"This":[42],"institutional":[43],"review":[44],"board-approved":[45],"retrospective":[46],"multicenter":[47],"included":[49],"serial":[50],"children":[51],"who":[52],"underwent":[53],"HCT":[54,112],"from":[55,83,102,237],"1":[56,60],"January":[57],"2015":[58],"July":[61],"2019.":[62],"A":[63],"standardized":[64],"unit":[65],"cost":[66,73,97,99],"(adjusted":[67],"geographic":[69],"location,":[70],"differences":[71],"living,":[75],"inflation)":[77],"hospitalization":[80],"extracted":[82],"Pediatric":[85],"Health":[86],"Information":[87],"System":[88],"data":[89],"linked":[91],"clinical":[93],"data.":[94],"Both":[95],"total":[96,212],"per":[100],"day":[101],"15":[103],"days":[104],"before":[105],"stem":[106],"infusion":[108],"1-year":[110],"were":[113,135,164],"calculated.":[114],"Among":[115,157],"allogeneic":[116],"(allo)":[117],"recipients,":[119],"adjusting":[121,185],"severe":[123],"grade":[124],"3/4":[125],"acute":[126],"graft-versus-host":[127],"disease":[128],"(GVHD),":[129],"infections,":[130],"HLA":[132],"mismatch,":[133],"not":[136,208],"different":[137],"(n":[140,146,171,180,195,201],"=":[141,147,172,181,196,202],"137)":[142],"vs":[143,198],"no":[144],"238).":[148],"Severe":[149],"GVHD":[150],"significantly":[152,165],"increased":[155,211,223],"costs.":[156,213],"allo":[158],"high-risk":[159],"(HR)":[160],"TMA-TMA,":[161],"unadjusted":[162],"higher":[166],"eculizumab-treated":[169],"cohort":[170],"19)":[173],"than":[174],"supportive":[177,199],"group":[179],"36).":[182],"However,":[183],"gastrointestinal":[187],"bleeding":[188],"that":[189],"occurred":[190],"disproportionately":[191],"eculizumab":[194,205],"6)":[197],"0)":[203],"cohort,":[204],"treatment":[206],"More":[214],"studies":[215],"needed":[217],"determine":[219],"etiology":[221],"HCU":[224,240],"those":[227,232],"HR-TA-TMA":[229],"predict":[231],"more":[233],"likely":[234],"benefit":[236],"eculizumab,":[238],"reducing":[239],"improving":[242],"outcomes.":[243]},"counts_by_year":[{"year":2026,"cited_by_count":4},{"year":2025,"cited_by_count":2}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2023-12-29T00:00:00"}